PTPN1 and diabetes mellitus: In particular, it was shown to selectively and reversibly inhibit protein tyrosin phosphatase 1B (PTP1B) [182], which is a validated target for obesity and diabetes [183], and its high expression is associated with poor prognosis in different types of cancer [184,185].